Sonire Therapeutics announced today that it initiated its first U.S. clinical trial, SUNRISE-II, evaluating its pancreatic ...

Sonire Therapeutics, a U.S.-based clinical-stage medical device company, today announced the initiation of its first U.S. clinical trial, SUNRISE-II, evaluating its proprietary High-Intensity Focused ...

Sonire’s first U.S. study of ultrasound-guided, anesthesia-free HIFU ablation therapy has been launched for patients with ...

When Ryan Myers was diagnosed last year, he thought he had just been handed a death sentence. Could a new treatment provide a ...

CHICAGO--(BUSINESS WIRE)--A new study shows that contrast enhanced ultrasound (CEUS) techniques offer an encouraging option for noninvasively detecting pancreatic cancer in its early stages, when ...

For many years, doctors and technicians who performed medical ultrasound procedures viewed bubbles with wary concern. The phenomenon of cavitation—the formation and collapse of tiny gas bubbles due to ...

Scientists at Oregon Health & Science University have developed a new technique using an electronic jolt and nanoparticles to ...